Stocks poised to open higher as investors weigh Gilead coronavirus treatment, GDP data

U.S. stocks were poised to open higher Wednesday as upbeat data on coronavirus treatment from Gilead Sciences offset fresh figures that showed U.S. economic growth contracted in the first quarter.